BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 04/01/2001

Draft Guidance on Potassium Iodide as a Thyroid Blocking Agent in Radiation Emergencies; Availability

The Food and Drug Administration (FDA) is announcing the availability of a draft guidance entitled "Potassium Iodide as a Thyroid Blocking Agent in Radiation Emergencies." This draft guidance updates a notice of availability entitled "Potassium Iodide as a Thyroid-Blocking Agent In a Radiation Emergency: Final Recommendations On Use" published in the Federal Register on June 29, 1982, concerning the prophylactic use of potassium iodide (KI) in the event of release of radioactive isotopes of iodine. In the draft guidance, FDA maintains its position that KI is a safe and effective means by which to prevent radioiodine uptake by the thyroid gland, under certain specified condition for use, and thus to obviate the risk of thyroid cancer in the event of a radiation emergency.

Source: Federal Register — Food and Drug AdministrationOpen original release →